Valuable lessons from SAPHO syndrome

Joint Bone Spine

Volumn 74, Issue 2, 2007, Pages 123-126

  Hayem, Gilles ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Anti TNF agents; Bisphosphonates; Propionibacterium acnes; Reactive osteitis; SAPHO syndrome

Indexed keywords

ETANERCEPT; INFLIXIMAB; METHOTREXATE; PAMIDRONIC ACID;

EDITORIAL; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; NONHUMAN; PAPA SYNDROME; PATHOPHYSIOLOGY; PREVALENCE; SAPHO SYNDROME; SPONDYLOARTHROPATHY; SYMPTOM;

ACQUIRED HYPEROSTOSIS SYNDROME; ANIMALS; ANTIRHEUMATIC AGENTS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; GENETIC PREDISPOSITION TO DISEASE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; PROPIONIBACTERIUM ACNES;

EID: 34247168578     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.06.006     Document Type: Editorial

References (44)

1. Hayem G., Bouchaud-Chabot A., Benali K., Roux S., Palazzo E., Silbermann-Hoffman O., et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29 (1999) 159-171
2. Beretta-Piccoli B.C., Sauvain M.J., Gal I., Schibler A., Saurenmann T., Kressebuch H., et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr 159 (2000) 594-601
3. Suei Y., Taguchi A., and Tanimoto K. Diagnostic points and possible origin of osteomyelitis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a radiographic study of 77 mandibular osteomyelitis cases. Rheumatology (Oxford) 42 (2003) 1398-1403
4. Costner M.I., and Sontheimer R.D. Osteoarthritis in 84 Japanese patients with palmoplantar pustulosis. J Am Acad Dermatol 33 (1995) 543
5. Van Doornum S., Barraclough D., McColl G., and Wicks I. SAPHO: rare or just not recognized?. Semin Arthritis Rheum 30 (2000) 70-77
6. Benhamou C.L., Chamot A.M., and Kahn M.F. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?. Clin Exp Rheumatol 6 (1988) 109-112
7. Edlund E., Johnsson U., Lidgren L., Pettersson H., Sturfelt G., Svensson B., et al. Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis 47 (1988) 809-815
8. Gerster J.C., Lagier R., and Livio J.J. Propionibacterium acnes in a spondylitis with palmoplantar pustulosis. Ann Rheum Dis 49 (1990) 337-338
9. Grassin Delyle L., Vittecoq O., Bourdel A., Duparc F., Michot C., and Le Loet X. Chronic destructive oligoarthritis associated with Propionibacterium acnes in a female patient with acne vulgaris: septic-reactive arthritis?. Arthritis Rheum 43 (2000) 2843-2847
10. Kotilainen P., Merilahti-Palo R., Lehtonen O.P., Manner I., Helander I., Mottonen T., et al. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J Rheumatol 23 (1996) 1302-1304
11. Schaeverbeke T., Lequen L., de Barbeyrac B., Labbe L., Bebear C.M., Morrier Y., et al. Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis. Arthritis Rheum 41 (1998) 1889-1893
12. Kirchhoff T., Merkesdal S., Rosenthal H., Prokop M., Chavan A., Wagner A., et al. Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up. Eur Radiol 13 (2003) 2304-2308
13. Wagner A.D., Mai U., Hammer M., and Zeidler H. Longterm antibiotic therapy in patients with SAPHO. Arthritis Rheum 9 Suppl (1997) S62
14. Kalis C., Gumenscheimer M., Freudenberg N., Tchaptchet S., Fejer G., Heit A., et al. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 174 (2005) 4295-4300
15. Naser S.A., Ghobrial G., Romero C., and Valentine J.F. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364 (2004) 1039-1044
16. Wagner A.D., Andresen J., Jendro M.C., Hulsemann J.L., and Zeidler H. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 46 (2002) 1965-1968
17. Carpenter E., Jackson M.A., Friesen C.A., Scarbrough M., and Roberts C.C. Crohn's-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr 144 (2004) 541-544
18. Olivieri I., Padula A., Ciancio G., Salvarani C., Niccoli L., and Cantini F. Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 61 (2002) 375-376
19. Darley C.R., Currey H.L., and Baker H. Acne fulminans with arthritis in identical twins treated with isotretinoin. J R Soc Med 77 (1984) 328-330
20. Gonzalez T., Gantes M., Bustabad S., and Diaz-Flores L. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol 12 (1985) 389-391
21. Byrd L., Grossmann M., Potter M., and Shen-Ong G. Chronic multifocal osteomyelitis, a new recessive mutation on chromosome 18 of the mouse. Genomics 11 (1991) 794-798
22. Ferguson P.J., Bing X., Vasef M.A., Ochoa L.A., Mahgoub A., Waldschmidt T.J., et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 38 (2006) 41-47
23. Li J., Nishizawa K., An W., Hussey R.E., Lialios F.E., Salgia R., et al. A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion. Embo J 17 (1998) 7320-7336
24. Baum W., Kirkin V., Mateus Fernandez S.B., Pick R., Lettau M., Janssen O., et al. Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. J Biol Chem 280 (2005) 40012-40024
25. Golla A., Jansson A., Ramser J., Hellebrand H., Zahn R., Meitinger T., et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 10 (2002) 217-221
26. Lindor N.M., Arsenault T.M., Solomon H., Seidman C.E., and McEvoy M.T. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72 (1997) 611-615
27. Yeon H.B., Lindor N.M., Seidman J.G., and Seidman C.E. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 66 (2000) 1443-1448
28. Wise C., Gillum J., Seidman C., Lindor N., Veile R., Bashiardes S., et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11 (2002) 961-969
29. Majeed H.A., Kalaawi M., Mohanty D., Teebi A.S., Tunjekar M.F., al-Gharbawy F., et al. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr 115 (1989) 730-734
30. Ferguson P.J., Chen S., Tayeh M.K., Ochoa L., Leal S.M., Pelet A., et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42 (2005) 551-557
31. Bognar M., Blake W., and Agudelo C. Chronic recurrent multifocal osteomyelitis associated with Crohn's disease. Am J Med Sci 315 (1998) 133-135
32. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
33. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278 (2003) 8869-8872
34. Hampe J., Grebe J., Nikolaus S., Solberg C., Croucher P.J., Mascheretti S., et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359 (2002) 1661-1665
35. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schaffeler E., Schlee M., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal {alpha}-defensin expression. Gut 53 (2004) 1658-1664
36. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
37. Maeda S., Hsu L.C., Liu H., Bankston L.A., Iimura M., Kagnoff M.F., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
38. Guignard S., Job-Deslandre C., Sayag-Boukris V., and Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 69 (2002) 392-396
39. Kerrison C., Davidson J.E., Cleary A.G., and Beresford M.W. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 43 (2004) 1246-1251
40. Amital H., Applbaum Y.H., Aamar S., Daniel N., and Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 43 (2004) 658-661
41. Solau-Gervais E., Soubrier M., Gerot I., Grange L., Puechal X., Sordet C., et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology (Oxford) 45 3 (2006) 339-342
42. Deutschmann A., Mache C.J., Bodo K., Zebedin D., and Ring E. Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-alpha blockage. Pediatrics 116 (2005) 1231-1233
43. Massara A., Cavazzini P.L., and Trotta F. SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 45 (2006) 730-733
44. Huber A.M., Lam P.Y., Duffy C.M., Yeung R.S., Ditchfield M., Laxer D., et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr 141 (2002) 198-203